NCT00471939View on ClinicalTrials.gov

Safety and Efficacy of I-020502 in Meshed Skin Autografting

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

January 31, 2009

Conditions
Burns
Interventions
DRUG

I-020502

1 mcg/mL TG-PDGF.AB

Trial Locations (1)

44789

Universitätsklinik für Plastische Chirurgie und Schwerbrandverletzte, Bochum

Sponsors

Collaborators (1)

Baxter BioScience
All Listed Sponsors
collaborator

Baxter BioScience

INDUSTRY

lead

Kuros Biosurgery AG

INDUSTRY

NCT00471939 - Safety and Efficacy of I-020502 in Meshed Skin Autografting | Biotech Hunter | Biotech Hunter